TY  - GEN
AU  - Hong,Soon Jun
AU  - Jeong,Han Saem
AU  - Ahn,Jeong Cheon
AU  - Cha,Dong-Hun
AU  - Won,Kyung Heon
AU  - Kim,Weon
AU  - Cho,Sang Kyoon
AU  - Kim,Seok-Yeon
AU  - Yoo,Byung-Su
AU  - Sung,Ki Chul
AU  - Rha,Seung-Woon
AU  - Shin,Joon-Han
AU  - Han,Kyoo Rok
AU  - Chung,Wook Sung
AU  - Hyon,Min Su
AU  - Lee,Han Cheol
AU  - Bae,Jang-Ho
AU  - Rhee,Moo-Yong
AU  - Kwan,Jun
AU  - Jeon,Dong Woon
AU  - Yoo,Ki Dong
AU  - Kim,Hyo-Soo
TI  - A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
SN  - 1879-114X
PY  - 2019///0226
KW  - Aged
KW  - Anticholesteremic Agents
KW  - administration & dosage
KW  - Cholesterol, LDL
KW  - blood
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Ezetimibe
KW  - Female
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hypercholesterolemia
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Republic of Korea
KW  - Rosuvastatin Calcium
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.clinthera.2017.12.018
ER  -